Navigation Links
AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimer's Disease
Date:9/15/2008


WILMINGTON, Del., Sept. 15 /PRNewswire-FirstCall/ --

-- Results inconclusive, as primary outcome measure not statistically

significant for either donepezil or AZD3480; results impacted by

improvement in placebo group

-- Improvements shown on secondary outcome measures ADCS-CGIC and MMSE

-- Overall safety and tolerability profile comparable to placebo, with

fewer GI-related AEs than donepezil

-- Next steps include further analysis of full dataset and planned

discussions with leading medical experts

AstraZeneca (NYSE: AZN) and Targacept, Inc. today announced that results from the Phase IIb clinical trial of AZD3480 (TC-1734) conducted by AstraZeneca in mild to moderate Alzheimer's disease were inconclusive.

In the 12-week placebo-controlled study, known as the Sirocco trial, neither the active comparator donepezil nor AZD3480 met the trial's criteria for statistical significance on the primary outcome measure, ADAS-Cog (Alzheimer's Disease Assessment Scale -- Cognition Subscale.) Both results were impacted by an improvement in the placebo group.

At two of the three doses tested, AZD3480 showed an improvement on the secondary outcome measures ADCS-CGIC (Alzheimer's Disease Cooperative Study -- Clinical Global Impression of Change, a 7-point scale), a widely accepted measure of clinician assessment of change in patients' behavior and ability to function, and MMSE (Mini Mental State Examination, a 30-point scale), a quantitative cognition scale commonly used by neurologists in a clinical setting. Of the three AZD3480 doses, the middle dose performed best on both measures (0.5 point improvement, ADCS-CGIC and 0.9 point improvement, MMSE). Donepezil also sh
'/>"/>

SOURCE AstraZeneca
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds
2. AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six
3. Phase III Study of Abbotts Investigational TriLipix(TM) in Combination With AstraZenecas CRESTOR(R) Meets Primary Endpoints on Key Lipids
4. AstraZeneca Submits sNDA for NEXIUM(R) I.V. for Peptic Ulcer Bleed Indication
5. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
6. AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines
7. Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca
8. AstraZeneca Submits an sNDA for SYMBICORT(R) for COPD Indication
9. AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression
10. AstraZeneca Completes Enrollment in First Phase III Study of the Investigational Drug Vandetanib (ZACTIMA)(R) in Non-Small Cell Lung Cancer
11. New Analysis of METEOR Study Demonstrate Effects of AstraZenecas CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... , July 25, 2014 /PRNewswire-iReach/ -- Full ... as the new Vice President of Business Development. ... 30 years in a number of different business development ... industry. These positions were primarily related to business development/sales ... the past 30 years makes him a key and ...
(Date:7/25/2014)...  Acsis Inc., the market leader for supply ... recently posted an article, "Future of Running ... needs for companies, extended supply chain, and explains ... no longer work today.  The article explains how ... mobile technology, machine to machine (M2M) connectivity, and ...
(Date:7/25/2014)... July 25, 2014  IDEXX Laboratories, Inc. (NASDAQ: ... second quarter of 2014 increased 11% versus the prior ... for the second quarter of 2014 versus the ... changes in distributor inventory 2 . Earnings per diluted ... increased 11% from the prior year period to $1.10."In ...
Breaking Medicine Technology:Contract Research Organization WCCT Global Welcomes Peter Nieto as Vice President of Business Development 2Acsis Addresses Questions on the Modern Supply Chain 2IDEXX Laboratories Announces Second Quarter Results 2IDEXX Laboratories Announces Second Quarter Results 3IDEXX Laboratories Announces Second Quarter Results 4IDEXX Laboratories Announces Second Quarter Results 5IDEXX Laboratories Announces Second Quarter Results 6IDEXX Laboratories Announces Second Quarter Results 7IDEXX Laboratories Announces Second Quarter Results 8IDEXX Laboratories Announces Second Quarter Results 9IDEXX Laboratories Announces Second Quarter Results 10IDEXX Laboratories Announces Second Quarter Results 11IDEXX Laboratories Announces Second Quarter Results 12IDEXX Laboratories Announces Second Quarter Results 13IDEXX Laboratories Announces Second Quarter Results 14IDEXX Laboratories Announces Second Quarter Results 15IDEXX Laboratories Announces Second Quarter Results 16IDEXX Laboratories Announces Second Quarter Results 17IDEXX Laboratories Announces Second Quarter Results 18IDEXX Laboratories Announces Second Quarter Results 19IDEXX Laboratories Announces Second Quarter Results 20IDEXX Laboratories Announces Second Quarter Results 21IDEXX Laboratories Announces Second Quarter Results 22IDEXX Laboratories Announces Second Quarter Results 23IDEXX Laboratories Announces Second Quarter Results 24IDEXX Laboratories Announces Second Quarter Results 25IDEXX Laboratories Announces Second Quarter Results 26IDEXX Laboratories Announces Second Quarter Results 27IDEXX Laboratories Announces Second Quarter Results 28IDEXX Laboratories Announces Second Quarter Results 29IDEXX Laboratories Announces Second Quarter Results 30IDEXX Laboratories Announces Second Quarter Results 31IDEXX Laboratories Announces Second Quarter Results 32IDEXX Laboratories Announces Second Quarter Results 33IDEXX Laboratories Announces Second Quarter Results 34
(Date:7/26/2014)... (PRWEB) July 26, 2014 The European Artificial ... in Europe with analysis and forecast of revenue. The artificial ... $3.5 billion in 2013 to around $5.4 billion by 2018, ... , Browse through the TOC of European artificial lift market ... also provides a glimpse of the segmentation in European Artificial ...
(Date:7/26/2014)... “Today, we introduce our new items of prom ... All these models are offered at discounted prices, and ... says the CEO of the company. DressesOnlineShops.co.uk is one ... outfits. , Ladies have to find a dress solution ... the best choices for many ladies worldwide to buy ...
(Date:7/26/2014)... 2014 “Healthy teeth are important, and having ... whites shining,” says Community Health Center of Snohomish County (CHC) ... They believe that an integration of medical and dental care ... Because of this, they encourage regular cleanings and checkups not ... , “Children and adults will find knowledgeable and ...
(Date:7/26/2014)... (PRWEB) July 26, 2014 Another DePuy Pinnacle ... Orthopedics, Inc., has been filed by Wright & Schulte LLC. ... on behalf of an Erie County, Ohio man who ... left hip and groin since receiving his Pinnacle Hip implant ... man will be forced to undergo a complex and risky ...
(Date:7/26/2014)... 26, 2014 As the category ... true vision of Xoçai is to ... exclusive and healthy chocolate products. One such unique ... cacao, açaí berries and blueberries, an ingredient combination ... blend is utilized in all of Xoçai products ...
Breaking Medicine News(10 mins):Health News:Europe Artificial Lift Services Market is Expected to Reach $5.4 Billion in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Artificial Lift Services Market is Expected to Reach $5.4 Billion in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Artificial Lift Services Market is Expected to Reach $5.4 Billion in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Artificial Lift Services Market is Expected to Reach $5.4 Billion in 2018 - New Report by MicroMarket Monitor 5Health News:Famous Supplier DressesOnlineShops.co.uk Announces Its New Selection of Prom Dresses for the UK Market 2Health News:Common Dental Care Questions Answered by Community Health Center of Snohomish County in Recent Article 2Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Recipient Who Faces Surgery To Replace Artificial Hip Implant 2Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Recipient Who Faces Surgery To Replace Artificial Hip Implant 3Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Recipient Who Faces Surgery To Replace Artificial Hip Implant 4Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Recipient Who Faces Surgery To Replace Artificial Hip Implant 5Health News:Xocai-Asia Japanese Distributors in Hachioji, Japan Sanction Local Single-Source-Chocolate Investigative Report: MXI-Corp-Asia Discloses Direct-Sales Compensation Plan 2Health News:Xocai-Asia Japanese Distributors in Hachioji, Japan Sanction Local Single-Source-Chocolate Investigative Report: MXI-Corp-Asia Discloses Direct-Sales Compensation Plan 3Health News:Xocai-Asia Japanese Distributors in Hachioji, Japan Sanction Local Single-Source-Chocolate Investigative Report: MXI-Corp-Asia Discloses Direct-Sales Compensation Plan 4
... Health Solutions, Inc. (NYSE: MHS ) Chairman ... deliver the Keynote Luncheon Address to the American Enterprise ... Care?" on Wednesday, March 18, 2009, at 12:30 p.m. ... federal funding will be directed at expanding the use ...
... Offers Life Saving Tips to Prevent Accidental PoisoningSAN ... poisonings are reported each year to poison control ... California Poison Control System (CPCS) is dedicated to ... 24-hour assistance relating to poisoning. National Poison ...
... Using a novel genetic technology that covers up genetic ... of Health have developed a successful treatment for dogs ... paralyzing, and ultimately fatal, muscle disease. , The technology, ... molecules as molecular "patches." These patches cover up mutant ...
... French-Israeli scientific agreement, known as the European Associated ... Hebrew University of Jerusalem on Wednesday, March 18, ... in Neuroscience. , The new agreement marks ... as the France-Israel International Associated Laboratory Agreement, which ...
... - A researcher has developed probes that can help ... be able to directly attack cancer cells. , Joseph ... biological engineering, developed the nanoscale, multifunctional probes, which have ... cancer cells. , A paper detailing the technology was ...
... INDIANAPOLIS, March 16 More than 35,000 people had ... surgery less than six weeks after diagnosis, according to ... period, conducted by HealthCore, WellPoint,s outcomes research subsidiary.Many people ... out of 10 Americans at some point in their ...
Cached Medicine News:Health News:Media Advisory: Medco CEO David B. Snow Jr. To Address American Enterprise Institute: 'Health IT: Empowering Precision Medicine' 2Health News:Poison Prevention Week March 15 - 22 2Health News:Poison Prevention Week March 15 - 22 3Health News:Researchers develop DNA 'patch' for canine form of muscular dystrophy 2Health News:Researchers develop DNA 'patch' for canine form of muscular dystrophy 3Health News:France-Israel scientific cooperation agreement 2Health News:Nanoscopic probes can track down and attack cancer cells 2Health News:Tens of Thousands of Back Pain Patients Overtreated in Six Health Plans, According to HealthCore Study 2Health News:Tens of Thousands of Back Pain Patients Overtreated in Six Health Plans, According to HealthCore Study 3Health News:Tens of Thousands of Back Pain Patients Overtreated in Six Health Plans, According to HealthCore Study 4Health News:Tens of Thousands of Back Pain Patients Overtreated in Six Health Plans, According to HealthCore Study 5
Tube for Right Bronchus - Ruschelit™ PVC. Color coded for easy identification of ports, balloons and 15mm connectors. High volume/low pressure cuffs. X-ray opaque line. Graduated. Single use. S...
Tube for Left Bronchus - Ruschelit™ PVC. Color coded for easy identification of ports, balloons and 15mm connectors. High volume/low pressure cuffs. With Carina hook. X-ray opaque line. Graduat...
... For Laryngotracheal Instillation of Topical Anesthetic, ... populations, this cuffed tube incorporates an ... spray application of topical anesthetic above ... offers three endotracheal tubes designs which ...
Laryngectomy Tubes with special J-shape for convenient placement through a tracheostomy stoma....
Medicine Products: